Request for Information (RFI) and Industry Day Announcement: Host-Directed Therapeutics for Prophylaxis, Post-Exposure Prophylaxis and Treatment of Exposure to Viruses, Bacteria and Toxins
Closed Pre-Solicitation Posted
- Solicitation number
- W911SR-24-S-HDTX
- Agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Alexandria, Virginia 22314, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of the Army Materiel Command Army Contracting Command Aberdeen Proving Ground (ACC Aberdeen Proving Ground) has issued a Request for Information (RFI) and Industry Day Announcement for the development of host-directed therapeutics for prophylaxis, post-exposure prophylaxis, and treatment of exposure to viruses, bacteria, and toxins. The Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical) and the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) are seeking information on the available capabilities and willingness of private entities to collaborate with the government in this area. The evaluation criteria cover competitive advantage, solution's advantages, degree of innovation, potential for impact, clinical risk, commercial risk, and commercialization potential.
This RFI is for planning purposes only and does not guarantee a solicitation. The government intends to use an Other Transaction Agreement (OTA) as the first choice for any subsequent acquisition, and respondents are encouraged to join the Medical CBRND Defense Consortium. There is no set-aside designation, and no information is provided on potential incumbents or current contractors. The RFI does not specify award values or budget ranges, nor does it provide details on the quantity of goods or timeline for services.
Notice text
This is a Request for Information (RFI) for planning purposes only. It is not to be construed as a commitment by the Government nor will the Government pay for the information solicited.
JPM CBRN Medical is hosting an Industry Day 29 October 2024 at the United States Patent and Trademark Office (USPTO) in Alexandria, VA. This event will provide Industry the chance to hear from US Government agencies on current and future work in the arena of Host Directed Therapeutics. Presentations will be given by JPEO CBRND, BARDA, and JSTO. The following day, 30 October, selected companies can present their product to USG representatives. Those companies will be selected based on responses to this RFI.
No solicitation document exists or is guaranteed to be issued as a result of this RFI or in person presentation. The Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical) and the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) is seeking information on the available capabilities and willingness of private entities (academic, non-profit, and commercial) to collaborate with the Government in the areas listed below.
The JPEO-CBRND is interested in late-stage development of host-directed therapeutics or repurposing of United States Food and Drug Administration (FDA) licensed therapeutics that are threat-agnostic with the potential for activity across viral families, bacterial species or toxin families.
Please see the attached RFI for a full list of performance objectives and information requested.
Files
| File | Type | Posted |
|---|---|---|
| Evaluation Criteria.pdf | ||
| W911SR-24-S-HDTX RFI.pdf | ||
| White Paper Template.pdf |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity